Biasing human epidermal growth factor receptor 4 (HER4) tyrosine kinase signaling with antibodies: Induction of cell death by antibody‐dependent HER4 intracellular domain trafficki...

por Lanotte, Romain, Garambois, Véronique, Gaborit, Nadège, Larbouret, Christel, Musnier, Astrid, Martineau, Pierre, Pèlegrin, André, Chardès, Thierry
Publicado 2020

Quantification of HER Expression and Dimerization in Patients’ Tumor Samples Using Time-Resolved Förster Resonance Energy Transfer

por Ho-Pun-Cheung, Alexandre, Bazin, Hervé, Gaborit, Nadège, Larbouret, Christel, Garnero, Patrick, Assenat, Eric, Castan, Florence, Bascoul-Mollevi, Caroline, Ramos, Jeanne, Ychou, Marc, Pèlegrin, André, Mathis, Gérard, Lopez-Crapez, Evelyne
Publicado 2012

A recycling anti-transferrin receptor-1 monoclonal antibody as an efficient therapy for erythroleukemia through target up-regulation and antibody-dependent cytotoxic effector funct...

por Neiveyans, Madeline, Melhem, Rana, Arnoult, Christophe, Bourquard, Thomas, Jarlier, Marta, Busson, Muriel, Laroche, Adrien, Cerutti, Martine, Pugnière, Martine, Ternant, David, Gaborit, Nadège, Chardès, Thierry, Poupon, Anne, Gouilleux-Gruart, Valérie, Pèlegrin, Andre, Poul, Marie-Alix
Publicado 2019

Targeting HER3, a Catalytically Defective Receptor Tyrosine Kinase, Prevents Resistance of Lung Cancer to a Third-Generation EGFR Kinase Inhibitor

por Romaniello, Donatella, Marrocco, Ilaria, Belugali Nataraj, Nishanth, Ferrer, Irene, Drago-Garcia, Diana, Vaknin, Itay, Oren, Roni, Lindzen, Moshit, Ghosh, Soma, Kreitman, Matthew, Kittel, Jeanette Clarissa, Gaborit, Nadege, Bergado Baez, Gretchen, Sanchez, Belinda, Eilam, Raya, Pikarsky, Eli, Paz-Ares, Luis, Yarden, Yosef
Publicado 2020

An oligoclonal antibody durably overcomes resistance of lung cancer to third‐generation EGFR inhibitors

por Mancini, Maicol, Gal, Hilah, Gaborit, Nadège, Mazzeo, Luigi, Romaniello, Donatella, Salame, Tomer Meir, Lindzen, Moshit, Mahlknecht, Georg, Enuka, Yehoshua, Burton, Dominick GA, Roth, Lee, Noronha, Ashish, Marrocco, Ilaria, Adreka, Dan, Altstadter, Raya Eilam, Bousquet, Emilie, Downward, Julian, Maraver, Antonio, Krizhanovsky, Valery, Yarden, Yosef
Publicado 2017

HER3 as biomarker and therapeutic target in pancreatic cancer: new insights in pertuzumab therapy in preclinical models

por Thomas, GaëLle, ChardèS, Thierry, Gaborit, NadèGe, Mollevi, Caroline, Leconet, Wilhem, Robert, Bruno, Radosevic-Robin, Nina, Penault-Llorca, FréDéRique, Gongora, CéLine, Colombo, Pierre-Emmanuel, Lazrek, Yassamine, Bras-Goncalves, Rui, Savina, Ariel, Azria, David, Bazin, Hervé, PèLegrin, André, Larbouret, Christel
Publicado 2014